Mycobacterium abscessus: a new antibiotic nightmare

The intrinsic and acquired resistance of Mycobacterium abscessus to commonly used antibiotics limits the chemotherapeutic options for infections caused by these mycobacteria. Intrinsic resistance is attributed to a combination of the permeability barrier of the complex multilayer cell envelope, drug...

Full description

Saved in:
Bibliographic Details
Published inJournal of antimicrobial chemotherapy Vol. 67; no. 4; pp. 810 - 818
Main Authors Nessar, Rachid, Cambau, Emmanuelle, Reyrat, Jean Marc, Murray, Alan, Gicquel, Brigitte
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.04.2012
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text
ISSN0305-7453
1460-2091
1460-2091
DOI10.1093/jac/dkr578

Cover

Loading…
More Information
Summary:The intrinsic and acquired resistance of Mycobacterium abscessus to commonly used antibiotics limits the chemotherapeutic options for infections caused by these mycobacteria. Intrinsic resistance is attributed to a combination of the permeability barrier of the complex multilayer cell envelope, drug export systems, antibiotic targets with low affinity and enzymes that neutralize antibiotics in the cytoplasm. To date, acquired resistance has only been observed for aminoglycosides and macrolides, which is conferred by mutations affecting the genes encoding the antibiotic targets (rrs and rrl, respectively). Here we summarize previous and recent findings on the resistance of M. abscessus to antibiotics in light of what has been discovered for other mycobacteria. Since we can now distinguish three groups of strains belonging to M. abscessus (M. abscessus sensu stricto, Mycobacterium massiliense and Mycobacterium bolletii), studies on antibiotic susceptibility and resistance should be considered according to this new classification. This review raises the profile of this important pathogen and highlights the work needed to decipher the molecular events responsible for its extensive chemotherapeutic resistance.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Literature Review-2
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ObjectType-Feature-2
ObjectType-Review-3
ISSN:0305-7453
1460-2091
1460-2091
DOI:10.1093/jac/dkr578